A Multi-Million “Treasure Hunter” Is Serving the Duke Research Enterprise
The Duke Nuclear Magnetic Resonance spectroscopy (NMR) Center provides seven "state-of-the-art, multi-million-dollar instruments where researchers can run their experiments for very affordable fees.
Antibody Targets Deep-Seated KRAS Cancer Mutations
Immunologist Jose R. Conejo-Garcia, MD, PhD, unveils an antibody that successfully targets once-untreatable KRAS cancer mutations.
Duke Researchers Probe the Magic of Psychedelics as Medicine
Duke scholars are studying how hallucinogenic drugs might become alternative treatments for medical-resistant conditions.
From Migrant Farm Worker to Duke Scientist, Everardo Macias Tackles Prostate Cancer
Everardo Macias's quest to find innovative treatments for prostate cancer mirrors his own incredible journey – from a migrant farm worker to a groundbreaking scientist.
Surprise Discovery Reveals Key Factor in Multiple Sclerosis
Immunologists identify a pivotal protein in the progression of MS. Could blocking it be the future of treatment?
Felicia Pagliuca Follows Her Fascination
When Felicia Pagliuca arrived at Duke as a first-year undergraduate student from Asheville, she was only 16, but she was already fascinated by biology and physics. She knew she wanted to do scientific research “someday.”
Two Duke Scientists Awarded NIH Grants for High-Risk, High-Reward Research
The National Institutes of Health (NIH) has awarded grants to two Duke University School of Medicine faculty members through the NIH Common Fund’s High-Risk, High-Reward (HRHR) Research Program.
Using Gene Therapy to Treat Brain Disease
Doug Marchuk, PhD, James B. Duke Distinguished Professor of Molecular Genetics and Microbiology, and Aravind Asokan, PhD, professor in surgery, have been awarded a three-year $1.9 million grant from the Department of Defense to develop less invasive treatment options for familial cerebral cavernous malformations (CCM).
Chancellor’s Scholars Awards Recognize Diversity, Academic Excellence
The new scholars are outstanding first-year students from historically under-represented or underserved backgrounds who are pursuing a PhD.
Duke University Celebrates Nobel Prize Winner Robert Lefkowitz’s 50 Years of Scientific Discovery
Duke School of Medicine Symposium on Oct. 2-3 celebrates Robert Lefkowitz's 50- year career at Duke and honors his legacy of Nobel Prize-winning insights that transformed modern medicine.